Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288

Antiviral Research

Volumn 34, Issue 3, 1997, Pages 121-130

  Agatsuma, Toshinori ^a   Abe, Kohji ^a   Furukawa, Hidehiko ^a   Koga, Rika ^a   Koizumi, Makoto ^a   Hotoda, Hitoshi ^a   Kaneko, Masakatsu ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

HIV 1; Immunodeficient mouse; Oligonucleotide; SCID

Indexed keywords

ANTIVIRUS AGENT; OLIGONUCLEOTIDE; R 95288; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COCULTURE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; CHIMERA; DISEASE MODELS, ANIMAL; DNA, VIRAL; DRUG EVALUATION, PRECLINICAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTE TRANSFUSION; MALE; MICE; MICE, SCID; OLIGONUCLEOTIDES; SPLEEN; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

EID: 0030902964     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)01032-2     Document Type: Article

References (25)

1. Agatsuma, T., Furukawa, H., Hotoda, H., Koizumi, M., Koga, R. and Kaneko, M. (1997) Anti-human immunodeficiency virus type 1 activity of phosphodiester hexadeoxyribonucleotide modified by dibenzyloxybenzyl and hydroxyethyl residues at the 5′- and 3′-ends, R-95288. Antiviral Res. submitted.
2. Bridges, C.G., Taylor, D.L., Ahmed, P.S., Brennan, T.M., Hornsperger, J.M., Nave, J.F., Casara, P. and Tyms, A.S. (1996) MDL 74968 A new acyclonucleotide Analog: Activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection. Antimicrob. Agents Chemother. 40, 1072-1077.
3. Croy, B.A. and Chapeau, C. (1990) Evaluation of the pregnancy immunotropism hypothesis by assessment of the reproductive performance of young adult mice of genotype scid/scid, bg/bg. J. Reprod. Fert. 88, 231-239.
4. Furukawa, H., Momota, K., Agatsuma, T., Yamamoto, Y., Kimura, S. and Shimada, K. (1994) Mechanism of inhibition in vitro by guanine-rich oligonucleotides modified at the 5′terminal with dimethoxytrytyl residues. Nucleic Acids Res. 22, 5621-5627.
5. Furukawa, H., Momota, K., Agatsuma, T., Yamamoto, I., Kimura, S. and Shimada, K. (1997) Identification of a phosphodiester hexaoligonucleotide that inhibit HIV-1 replication in vitro upon covalent linkage of its 5′-end with dimethoxytrytyl residue, Antisense Res. Dev., accepted.
6. Gauduin, M.-C., Safrit, J.T., Weir, R. Fung, M.S.C. and Koup, R.A. (1995) Pre- and post exposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J. Infect. Dis. 171, 1203-1209.
7. Koga, R., Koizumi, M., Hotoda, H., Momota, K., Ohmine, T., Furukawa, H., Nishigaki, T., Kosaka, T. and Kaneko, M. (1996) Biologically active oligonucleotides-VI: Structure-activity relationships of anti-HIV-1 hexadeoxyribonucleotides bearing 3′- and 5′-end-modifications. Antiviral Res. (9th International Conference on Antiviral Research), 47, A32.
8. Kuyk, R., Torbett, B.E. Gulizia, R.J., Leath, S., Mosier, D.E. and Koenig, S. (1994) Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J. Immunol. 153, 4826-4833.
9. Lee, T-H, Sunzeri, F.J., Tobler, L.H., Williams, B.G. and Busch, M.P. (1991) Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-α genes. AIDS, 5, 683-691.
10. Majumdar, C., Stein, C.A., Cohen, J.S., Broder, S. and Wilson, S.H. (1989) Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry, 28, 1340-1346.
11. Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C.A., Mitsuya, H., Wong-Staal, F., Cohen, J.S. and Broder, S. (1989) Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligonucleotide against rev (art/trs) in chronically infected cells. Proc. Natl. Sci. USA, 86, 4244-4249.
12. Mosier, D.E., Gulizia, R.J., Baird, S.M. and Wilson, D.B. (1988) Transfer of a functional immune system to mice with severe combined immunodeficiency. Nature 335, 256-259.
13. Mosier, D.E., Gulizia, R.J., Baird, S.M., Wilson, D.B., Spector D.H. and Spector, S.A. (1991) Human immunodeficiency virus infection of hu-PBL-SCID mice. Science 251, 791-794.
14. Mosier, D.E., Gulizia, R.J., MacIsaac, P.D., Corey, L. and Greenberg, P.D. (1993) Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA, 90, 2443-2447.
15. Mosier, D.E. and Sieberg, H. (1994) Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today, 15, 332-339.
16. Ojwang, J., Elbaggari, A., Marshall, H.B., Jayaraman, K., McGrath, M.S. and Rando, R.F. (1994) Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine. J Acq. Immune. Defic. Syndr. 7(6), 560-570.
17. Parren, P.W., Ditzel, H.D., Gulizia, R.J., Binley, J.M., Barbas, C., Burton, D.R. and Mosier, D.E. (1995) Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against gp120 CD4 binding site., AIDS 9, F1-6.
18. Safrit, J.T., Fung, M.S.C., Andrews, C.A., Braun, D.G., Sun, W.N.C., Chang, T.W. and Koup, R.A. (1993) hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal anitibody to the principal neutralizing determinant of envelope gp120. AIDS 7, 15-21.
19. Stein, C.A., Neckers, L.M., Nair, B.C., Mumbauer, S., Hoke, G. and Pal, R. (1991) Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J. Acq. Immune. Defic. Syndr. 4, 686-693.
20. Stein, C.A, 1995, Does antisense exist? Nature Medicine 1, 1119-1121.
21. Torbett, B.E., Picchio, G. and Mosier, D.E. (1991) hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunological Rev., 124, 139-164.
22. Tsai, C.C., Follis, K.E., Grant, R.F., Nolte, R.E., Barts, C.R., Benveniste, R.E. and Sager, P.R. (1993) Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus. J. Acq. Immune Defic. Syndr. 6, 1086-1092.
23. Ussery, M.A., Broud, D.D., Wood, O.L., Kunder, S.C., Black, P.L., Dailey, P.C., Wilber, J.C., Yang. L., Piatek, M.Jr. and Lifson, J.D. (1995) Antiviral agents reduce viral load and delay the detection of infected cells in vivo in the HIV-infected hu-PBMC SCID mouse model. Antiviral Res. (8th International Conference on Antiviral Research), 26, A238.
24. Ussery, M.A., Wood, O.L., Broud, D.D., Bacho, M., Kunder, S.C., Papermaster, S., Kiso, Y. and Black, P.L (1996) Antiviral ativity of the protease inhibitor KNI-272 in vivo in the HIV-infected HuPBMC-SCID mouse Model. Antiviral Res. (9th International Conference on Antiviral Research), 6, A18.
25. Watanabe, T., Hanzawa, H., Haruyama, H., Koizumi, M. and Kaneko, M. (1996) Analysis of stereo structure of anti-HIV-1 oligonucleotide, S-1443 (R-95288). Seikagaku, 68, 941, 3-P-0284.